subscribeSubscribe
price-trendAsk Us
VistaGen fails phase 2 depression trial, sparking stock rout

VistaGen fails phase 2 depression trial, sparking stock rout
Nick P.Taylor FIERCE BIOTECH
15 Nov 2019
Share Share
Microcap biotech VistaGen turned to pennystock after PhII result depression drug

Microcap biotech VistaGen turned to pennystock after PhII result depression drug
Amber Tong ENDPTS
03 May 2019
Share Share
VistaGen - Nanocap CNS Drug Chasing Ketamine Fame

VistaGen - Nanocap CNS Drug Chasing Ketamine Fame
SEEKING ALPHA
21 May 2018
Share Share
VistaGen Therapeutics Initiates Phase 2 Study of AV-101 for Major Depressive Disorder

VistaGen Therapeutics Initiates Phase 2 Study of AV-101 for Major Depressive Disorder
PRESS RELEASE
05 Apr 2018
Share Share
Investors unimpressed with VistaGen update on AV-101; shares down 16%

Investors unimpressed with VistaGen update on AV-101; shares down 16%
Douglas House SEEKING ALPHA
30 Dec 2017
Share Share
How Ketamine could cure depression

How Ketamine could cure depression
DRUG TARGET REVIEW
30 Jan 2017
Share Share